{"product_id":"portfolio-program-and-project-management-in-the-pharmaceutical-and-biotechnology-industries-isbn-9780470049662","title":"Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries","description":"This book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly experienced practitioners from within the industry on future directions for drug program management. The book integrates portfolio, program, and project management processes as fundamental for effective and efficient drug product development. Contributing expert authors provide their view of how the projectization approach can be taken forward by the drug industry over the coming years. \u003cp\u003ePreface ix\u003c\/p\u003e \u003cp\u003eAcknowledgments xi\u003c\/p\u003e \u003cp\u003eAbout the Authors xiii\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart One The Life Science Industry Context for Portfolio, Program, and Project Management\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1. A Review of Project Management in Life Science Industry Sectors 3\u003cbr\u003e\u003ci\u003eThomas R. Dunson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2. The Impact of Organizational Size on Drug Project Management 21\u003cbr\u003e\u003ci\u003eEric Morfin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3. Drug Development in Biotechnology and How We Can Do It Better 33\u003cbr\u003e\u003ci\u003eSusan Linna\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart Two The Portfolio, Program, and Project Management Approaches and Processes\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e4. An Overview of the Organization and Processes of Portfolio, Program, and Project Management 53\u003cbr\u003e\u003ci\u003ePete Harpum\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5. Portfolio Management in the Pharmaceutical Industry: Balancing Corporate Need with the Reality of Delivering Products to the Market 59\u003cbr\u003e\u003ci\u003eJohn Bennett\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6. Program Management in Drug Development 85\u003cbr\u003e\u003ci\u003ePauline Stewart-Long\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7. Project Control 101\u003cbr\u003e\u003ci\u003eMartin Powell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8. Managing Uncertainty in Drug Projects 135\u003cbr\u003e\u003ci\u003ePete Harpum and Thomas R. Dunson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9. Managing Drug Safety Risk 155\u003cbr\u003e\u003ci\u003eThomas R. Dunson and Eric Morfin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10. Developing Program Strategy 175\u003cbr\u003e\u003ci\u003ePete Harpum\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11. Developing Products with “Added Value” 197\u003cbr\u003e\u003ci\u003eTrevor J. Brown and Stephen Allport\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart Three Integrating the Processes\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e12. Integrated Business Processes to Support Cross-Functional Drug Development 227\u003cbr\u003e\u003ci\u003eMartin D. Hynes III\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13. Integrated Drug Development: From Cradle to Grave and from Lab to Market 239\u003cbr\u003e\u003ci\u003eStephen Allport and Terry Cooke-Davies\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14. The Development of P3M Capability in Drug Development Organizations 259\u003cbr\u003e\u003ci\u003eJohn Arrowsmith, Patrick Grogan, and Bob Moore\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15. Implementing Portfolio, Program, and Project Management Best Practices in Drug Development Organizations 287\u003cbr\u003e\u003ci\u003ePete Harpum, Ashley Jamieson, and Inge Fisher\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eBibliography 311\u003c\/p\u003e \u003cp\u003eIndex 313\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePETE HARPUM\u003c\/b\u003e is a Director of Harpum Consulting and has been consulting on Portfolio, Program, and Project Management (P3M) for some ten years. He chairs and contributes to many conferences and symposiums on P3M. Mr. Harpum's other activities include postgraduate lecturing and research on P3M for three world-class universities, and supporting the Association for Project Management, Project Management Institute, and the Drug Information Association in various ways.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eThe EXPANSIVE, ALL-IN-ONE GUIDE to SUCCESSFUL PHARMACEUTICAL PROJECT MANAGEMENT\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eTo improve the ways they currently manage projects and programs, pharmaceutical and biotechnology companies need reliable stewardship to direct future strategies. Unlike other industry sectors, they have yet to fully embrace the effective integrated processes of Portfolio, Program, and Project Management, otherwise referred to as P3M, to position themselves favorably in meeting challenges unique to the drug development business.\u003c\/p\u003e \u003cp\u003e\u003ci\u003ePortfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries\u003c\/i\u003e illustrates how high-quality program and project management is crucial for drug companies to remain competitive, to deliver good returns to investors, and ultimately to bring novel personalized medicine to patients with:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eA combination of theoretical insights and pragmatic examples from professionals who are all working in the industry\u003c\/li\u003e \u003cli\u003eCase studies with very detailed, real-life examples of how the management of drug development is actually done\u003c\/li\u003e \u003cli\u003eAnswers the pharmaceutical industry needs to streamline and make the drug development process more efficient\u003c\/li\u003e \u003cli\u003eThe full spectrum of management processes needed from the operational-ization of corporate strategy by portfolio management processes through to practical project control processes\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eCarefully divided into three main sections to cover topics such as the impact of organizational size on P3M; planning and control; and reducing product safety risk, this informative reference is structured to align both novices and professionals in drug program management with success in the wake of emerging trends.\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47989816557797,"sku":"NP9780470049662","price":136.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780470049662.jpg?v=1761785564","url":"https:\/\/k12savings.com\/es\/products\/portfolio-program-and-project-management-in-the-pharmaceutical-and-biotechnology-industries-isbn-9780470049662","provider":"K12savings","version":"1.0","type":"link"}